January 20, 2018


Government new health insurance scheme, growing ageing population to boost medical device market, report

South Africa medical device market is expected to grow at an annual rate of 8.97 percent during the 2018-2024 period due to public-private partnerships to develop hospitals, government new health insurance schemes and growing ageing population.

It is predicted that ageing population in South Africa will double by 2050 from the present figure.

Around 90 percent of the total"...

Continue Reading >

January 18, 2018


Emirates Hospital Invests Dh 10 Million in Advanced Neonatal Technologies for Its NICU

Emirates Hospital, a subsidiary of Emirates Healthcare, has announced its recent investment of AED ten million in advanced technology for the Neonatal Intensive Care Unit (NICU) at Emirates Hospital in Jumeirah, Dubai.

The level 3 NICU services will make the difference in the survival of the sickest premature and full-term babies. The state-of-the-art facility will provide services like total body cooling (therapeutic hypothermia) for neonatal asphyxia"...

Continue Reading >

January 18, 2018


AMR Industry Alliance: Report Shows Life Sciences Industry Alliance is Taking Action to Curb Antimicrobial Resistance, with More to Come

(AETOS Wire) -- Today, the AMR Industry Alliance launches its first report that shows the commitment of the life sciences industry to tackle the public health threat of antimicrobial resistance (AMR). The Alliance brings together over 100 biotech, diagnostics, generics and research-based biopharmaceutical companies and trade associations from 20 countries. The report was compiled by SustainAbility. The data and case studies collected in the Alliance report provide unique insights into the practical steps members are taking to respond to AMR in the areas of research and science, access, appropriate use, and the environment. The report presents data on AMR-relevant products, including therapeutic agents or technologies that have the potential to treat or prevent infectious diseases and/or combat resistance, including but not limited to antibiotics, vaccines, diagnostics, and novel approaches......

Continue Reading >

January 18, 2018


Premas, IncellDx Ink India Distribution Agreement

(AETOS Wire) -- Premas Life Sciences Pvt., Ltd. and IncellDx, Inc. announced today they have signed an exclusive distribution agreement. The commercial partnership brings the power of cell by cell multiplex diagnostics for solid tumors carcinomas that can now be analyzed for molecular and protein biomarkers by flow cytometry. Included in the deal are: IncellDx's patented single-cell assays for quantifying PD-L1 on tumor cells and immune cell subtypes; patented single-cell assay"...

Continue Reading >

January 18, 2018


President Clinton to Address Healthcare Leaders Focused on Eliminating Preventable Deaths in Hospitals at the 6th Annual World Patient Safety, Science & Technology Summit

(AETOS Wire) -- For the 6th year in a row, President Bill Clinton, the Founder of the Clinton Foundation and 42nd President of the United States, will deliver keynote remarks at the 6th Annual World Patient Safety, Science and Technology Summit held in London, England, February 23-25, 2018. President Clinton, who serves as Honorary Chair of the Patient Safety Movement Foundation’s Regional Network Chairs, joins an acclaimed group of global leaders, government representatives,"...

Continue Reading >

January 14, 2018


Emirates Healthcare Launches New Al Reef Medical Center

Emirates Healthcare company, a leading global healthcare provider and a subsidiary of Abu Dhabi-based investment group, KBBO, announced the launch of Al Reef Medical Center, as part of its expansion plans in Ras Al Khaimah. The grand opening ceremony for the new facility took place at Al Reef Building, Nakheel, in Ras Al Khaimah on 11 January 2018.

The launch was inaugurated by Sheikh Mohammed bin Kayed Al Qasimi, Chairman of Ras Al Khaimah Department"...

Continue Reading >

January 11, 2018


First Treatment for MERS Appears Safe in NIH Phase I Clinical Trial

SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical development company, announced its anti-MERS immunotherapy (SAB-301) appears safe in a Phase I Clinical Trial. Results of the study, sponsored, funded and conducted by National Institutes of Health (NIH) were published today in The Lancet Infectious Diseases. Presently, there are no approved vaccines or treatments for Middle East respiratory syndrome (MERS)–a newly discovered, contagious and sometimes fatal respiratory illness, caused by a virus known as MERS coronavirus (MERS-CoV). Since the first confirmed case in Saudi Arabia in 2012, the illness has spread to 27 countries and more than 2,000 people, with a fatality rate approaching 40%, according to the World Health Organization. “This is the first study to show the safety of a potential treatment for MERS,” said John H. Beigel, M.D., a medical affairs......

Continue Reading >

January 11, 2018


Ferring and the Chinese Academy of Sciences Collaborate to Advance Research in Reproductive Medicine

Ferring Pharmaceuticals and the Chinese Academy of Sciences (CAS) today announced a long-term collaboration to advance basic and translational research in reproductive medicine through the development of novel product candidates and therapeutic strategies.

As part of the agreement, a new jointly funded laboratory will be created within the CAS research facility in Beijing, China. Known as the ‘Ferring Institute of Reproductive Medicine’,"...

Continue Reading >

January 11, 2018


Parrish Medical Center Awarded Patient Safety Movement’s First 5-Star Hospital Ranking

The Patient Safety Movement Foundation (PSMF) today awarded Florida-based Parrish Medical Center with the first-ever Patient Safety Five-Star Hospital ranking for implementing all 13 Actionable Patient Safety Solutions (APSS) – evidence-based processes designed to help hospitals eliminate preventable deaths and improve patient care.

“We know that implementing all APSS, as a part of a comprehensive patient safety program, helps hospitals"...

Continue Reading >

January 9, 2018


BlueBird Finance & Projects oversees financing of a $165 million hospital project in Eastern Africa

BlueBird Finance & Projects reports successful closing of a $165 million complex financing package for an EPC Turnkey construction project of an innovative hospital, including medical equipment supply, in Eastern Africa.

The main EPC Contractor is a large international construction company. The hospital, the construction of which has recently commenced, shall be the most modern and professional in that country.


Continue Reading >

Forex News Headline

Forex Market Video